EU drug watchdog to weigh in on extended use for remdesivir by summer

Europe's drugs regulator said on Tuesday it was expecting to give an opinion before the summer on whether Gilead Sciences' remdesivir can be used to treat COVID-19 patients who do not need oxygen support.